Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier

Jeffrey J. Tosoian, Samuel R. Birer, R. Jeffrey Karnes, Jingbin Zhang, Elai Davicioni, Eric E. Klein, Stephen J. Freedland, Sheila Weinmann, Bruce J. Trock, Robert T. Dess, Shuang G. Zhao, William C. Jackson, Kosj Yamoah, Alan Dal Pra, Brandon A. Mahal, Todd M. Morgan, Rohit Mehra, Samuel Kaffenberger, Simpa S. Salami, Christopher KaneAlan Pollack, Robert B. Den, Alejandro Berlin, Edward M. Schaeffer, Paul L. Nguyen, Felix Y. Feng, Daniel E. Spratt*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier'. Together they form a unique fingerprint.

Medicine & Life Sciences